文献速递儿科影像心血管妇产影像US

胎儿水肿时宫内心脏干预的生存结局:IFCIR 回顾性队列研究

Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR).
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-06-11

本研究基于国际胎儿心脏干预登记系统(IFCIR)2001年1月至2024年9月的数据,纳入91例先天性心脏病合并非免疫性胎儿水肿病例。73例接受宫内心脏干预,总体出院生存率为35.6%,而期待治疗组仅1/18生存。

要点

  • 胎儿水肿合并CHD行FCI后出院生存率约三分之一,期待治疗预后极差。
  • 主动脉瓣球囊成形术是主要术式,出院生存率为39.3%。
  • FCI操作相关胎儿丢失率为20.5%,需充分知情。

核心结论

  • FCI对水肿胎儿可能带来生存获益,但操作相关丢失率达1/5,生存率低于非水肿FCI队列。

研究设计与样本

  • 回顾性病例队列研究,数据来自国际胎儿心脏干预登记系统的自愿上报数据库。
  • 纳入2001年1月至2024年9月诊断为先天性心脏病合并非免疫性胎儿水肿的91例母胎配对。
  • 胎儿水肿定义为至少两个腔隙存在异常积液或水肿。
  • 73例接受FCI,中位胎龄28.3周(范围19.6至34.7周)。

关键影像表现/征象

  • 水肿胎儿FCI术式包括主动脉瓣球囊成形61例、肺动脉瓣球囊成形5例、房间隔干预或支架置入4例、其他3例。
  • 73例接受FCI者中,15例发生操作相关胎儿丢失,另有10例宫内死亡。

诊断标准与关键数值

  • FCI总体操作相关胎儿丢失率为20.5%(15/73)。
  • 73例接受FCI者中26例(35.6%)存活至首次出院。
  • 主动脉瓣球囊成形术出院生存率为39.3%(24/61)。
  • 存活者中15/20例在有随访结局时为双心室循环。
  • 期待治疗未行FCI者仅1/18存活至出院。

临床应用与阅片要点

  • 水肿胎儿即使接受FCI,出院生存率仅约三分之一,产前咨询应客观告知预期。
  • 主动脉瓣球囊成形术是水肿胎儿FCI最常见术式,但操作相关丢失风险不可忽视。

局限性

  • 局部机构自愿上报数据,存在选择偏倚和登记完整性不确定。
  • 回顾性分析,缺乏统一操作指征与围术期管理方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To describe the pregnancy and postnatal outcomes of a large, retrospectively analyzed case-cohort series of pregnancies complicated by congenital heart disease (CHD) and fetal hydrops that were assessed for potential for fetal cardiac intervention (FCI).

METHODS: The International Fetal Cardiac Intervention Registry (IFCIR) collects diagnostic and procedure-related data on maternal-fetal dyads with CHD that are considered by fetal specialists to be potentially capable of benefiting from FCI, with data submitted voluntarily by local institutions. For this retrospective analysis, the IFCIR database was searched for all case entries of pregnancies with a diagnosis of CHD and coexistent non-immune fetal hydrops, defined as abnormal fluid or edema involving at least two compartments, between January 2001 and September 2024. Data on the underlying cardiac diagnosis, procedures performed and pregnancy and postnatal outcomes were collated.

RESULTS: At the time of data extraction, the IFCIR contained 864 recorded maternal-fetal dyads, of which 91 (10.5%) had fetal hydrops at initial evaluation. Of these, 73 (80.2%) underwent FCI, including aortic (n = 61) or pulmonary (n = 5) balloon valvuloplasty, atrial septal intervention and/or stent placement (n = 4) and other FCI (n = 3), at a median gestational age of 28.3 (range, 19.6-34.7) weeks. The overall rate of procedure-related fetal loss was 20.5% (15/73). There were an additional 10 intrauterine fetal deaths, and two cases were either terminated (n = 1) or lost to follow-up (n = 1). Overall, 21 neonates were liveborn preterm (< 37 weeks) and 25 were liveborn at term (≥ 37 weeks), with a median latency post-procedure to delivery of 8.9 (range, 0.3-18.4) weeks. Of the 73 cases that underwent FCI, 26 (35.6%) survived to first hospital discharge, including 39.3% (24/61) of patients who underwent aortic valvuloplasty, one patient who underwent atrial septal intervention and one patient who underwent pulmonary valvuloplasty. The majority of survivors had biventricular circulation (15/20 with available outcome) at the last follow-up. No procedure-related maternal complications were recorded. Only 1/18 patients managed expectantly without FCI survived to hospital discharge.

CONCLUSIONS: Our findings suggest a potential benefit of FCI in patients with hydrops, although the procedure-related loss rate of 1 in 5 was significant. While the survival rate was lower than that reported in non-hydropic cohorts with FCI, approximately one-third of hydropic fetuses that underwent FCI included in our analysis survived to hospital discharge. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Moon-Grady, Tulzer, Armstrong, et al. Invasive in-utero cardiac intervention in the hydropic fetus may improve survival: results from the International Fetal Cardiac Intervention Registry (IFCIR). Ultrasound Obstet Gynecol. 2026. PMID: 42281210. doi:10.1002/uog.70245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。